Chronic myelogenous leukemia

MeSH terms

• Algorithms
• Antimetabolites, Antineoplastic / therapeutic use
• Antineoplastic Agents / therapeutic use
• Antineoplastic Agents / toxicity
• Benzamides
• Cell Transformation, Neoplastic
• Chromosome Breakage
• Chromosomes, Human, Pair 22
• Chromosomes, Human, Pair 9
• Cytarabine / therapeutic use
• Cytogenetic Analysis*
• Disease Progression
• Drug Interactions
• Gene Fusion
• Hematopoietic Stem Cell Transplantation
• Hematopoietic Stem Cells / cytology*
• Humans
• Imatinib Mesylate
• Interferons / therapeutic use
• Karyotyping
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / etiology
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
• Piperazines / therapeutic use
• Piperazines / toxicity
• Practice Guidelines as Topic / standards*
• Pyrimidines / therapeutic use
• Pyrimidines / toxicity
• Recombinant Fusion Proteins / chemistry
• Recombinant Fusion Proteins / metabolism
• Remission Induction
• Secondary Prevention
• Translocation, Genetic
• Transplantation, Homologous